YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Pharma Ventures

August 30, 2013 | Pharma is getting more notice from venture capital these days. Clarus Ventures, for example, has backed three specific pharma projects including Phase III studies of an already-approved drug in a new indication. Wall Street Journal Blog
View Next Related Story
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.